Targeting CMPK2-intervened redox metabolism to mitigate hepatic ischemia-reperfusion injury
HIRI is a major clinical challenge that occurs when blood supply to the liver is temporarily interrupted and then restored, as commonly seen in liver resection and liver transplantation.
Read the full articleYou might also wanna read
Natural Compound Acteoside Protects the Liver by Targeting CMPK2
A research team has identified cytosine monophosphate kinase 2 (CMPK2) as a key molecular driver of hepatic ischemia-reperfusion injury (HIR
Ferroptosis inhibitor FXT-001 shows promise in improving liver and lung transplant outcomes by targeting ischemia-reperfusion injury
Veeckmans et al. demonstrate that ischemia-reperfusion injury triggers an early lipid peroxidation wave in human transplants. They further s
Scaling Organ-on-a-Chip Technology for Human-Relevant Drug Discovery
Learn how Organ-on-a-Chip technology supports human-relevant preclinical research and how Liver-Chip models can improve prediction of drug-i
Avoiding Recooling After Normothermic Machine Perfusion in Liver Transplantation
Conditions : Liver Transplantation (LT); Ischemia-Reperfusion Injury; Early Allograft Dysfunction Interventions : Procedure: No Recooling Be
Procedure aims to battle cancers that spread to liver
Associate Professor of Surgery and Chief of Hepatobiliary and Pancreatic Surgery Mashaal Dhir, MD, talks about hepatic artery infusion thera
A Study of Combination Therapy in Patients With Resectable Liver Cancer
Conditions : Liver Cancer (Primary and Metastatic) Interventions : Drug: Hepatic Arterial Infusion Chemotherapy Combined with Adebrelimab Pl
Comments
Sign in to join the conversation.
No comments yet. Be the first.